JW Lifescience Corporation

Informe acción KOSE:A234080

Capitalización de mercado: ₩179.2b

Salud financiera de hoja de balance de JW Lifescience

Salud financiera controles de criterios 6/6

JW Lifescience tiene un patrimonio de accionistas total de ₩170.2B y una deuda total de ₩44.6B, lo que sitúa su ratio deuda-patrimonio en 26.2%. Sus activos y pasivos totales son ₩261.9B y ₩91.7B respectivamente. El BAIT de JW Lifescience es de ₩34.3B, por lo que su ratio de cobertura de intereses es de 41.5. Tiene efectivo e inversiones a corto plazo que ascienden a ₩55.7B.

Información clave

26.2%

Ratio deuda-patrimonio

₩44.59b

Deuda

Ratio de cobertura de intereses41.5x
Efectivo₩55.72b
Patrimonio₩170.20b
Total pasivo₩91.70b
Activos totales₩261.90b

Actualizaciones recientes sobre salud financiera

We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Apr 20
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Jan 12
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Recent updates

Solid Earnings Reflect JW Lifescience's (KRX:234080) Strength As A Business

Nov 24
Solid Earnings Reflect JW Lifescience's (KRX:234080) Strength As A Business

We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Apr 20
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Introducing JW Lifescience (KRX:234080), A Stock That Climbed 36% In The Last Year

Mar 11
Introducing JW Lifescience (KRX:234080), A Stock That Climbed 36% In The Last Year

What Type Of Shareholders Make Up JW Lifescience Corporation's (KRX:234080) Share Registry?

Feb 21
What Type Of Shareholders Make Up JW Lifescience Corporation's (KRX:234080) Share Registry?

Is JW Lifescience Corporation (KRX:234080) A Smart Pick For Income Investors?

Feb 02
Is JW Lifescience Corporation (KRX:234080) A Smart Pick For Income Investors?

We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Jan 12
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Is It Smart To Buy JW Lifescience Corporation (KRX:234080) Before It Goes Ex-Dividend?

Dec 23
Is It Smart To Buy JW Lifescience Corporation (KRX:234080) Before It Goes Ex-Dividend?

Is JW Lifescience Corporation's (KRX:234080) Recent Performance Tethered To Its Attractive Financial Prospects?

Dec 23
Is JW Lifescience Corporation's (KRX:234080) Recent Performance Tethered To Its Attractive Financial Prospects?

How Much Did JW Lifescience's(KRX:234080) Shareholders Earn From Share Price Movements Over The Last Three Years?

Nov 27
How Much Did JW Lifescience's(KRX:234080) Shareholders Earn From Share Price Movements Over The Last Three Years?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₩124.0B) de A234080 superan a sus pasivos a corto plazo (₩59.5B).

Pasivo a largo plazo: Los activos a corto plazo de A234080 (₩124.0B) superan a sus pasivos a largo plazo (₩32.2B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: A234080 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de A234080 ha pasado de 38.7% a 26.2% en los últimos 5 años.

Cobertura de la deuda: La deuda de A234080 está bien cubierta por el flujo de caja operativo (125.9%).

Cobertura de intereses: Los pagos de intereses de la deuda de A234080 están bien cubiertos por el BAIT (41.5x cobertura).

Hoja de balance

Descubre empresas con salud financiera

7D

1Y

7D

1Y

7D

1Y